Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose.

Detalles Bibliográficos
Autores principales: Eliakim-Raz, Noa, Stemmer, Amos, Ghantous, Nassem, Ness, Asaf, Awwad, Muhammad, Leibovici-Weisman, Yaara, Stemmer, Salomon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305380/
https://www.ncbi.nlm.nih.gov/pubmed/35862048
http://dx.doi.org/10.1001/jamanetworkopen.2022.23090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305380/
https://www.ncbi.nlm.nih.gov/pubmed/35862048
http://dx.doi.org/10.1001/jamanetworkopen.2022.23090

Ejemplares similares